Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | 1 | 5 | 0 | 0 | €15.80 | €12.00 | -24.051% |
| Medicinova Inc. | 0 | 3 | 0 | 0 | €4.38 | €4.00 | -8.676% |
| Akero Therapeutics Inc | 0 | 3 | 0 | 0 | €24.20 | €23.00 | -4.959% |
| Precipio Inc | 1 | 4 | 0 | 0 | €2.24 | €1.00 | -55.357% |
| India Globalization Capital | 1 | 4 | 0 | 0 | €1.46 | €1.00 | -31.638% |
| Aerie Pharmaceuticals Inc. | 0 | 2 | 0 | 0 | €15.30 | €8.00 | -47.712% |
| Pieris Pharmaceuticals Inc | 1 | 3 | 0 | 0 | €2.26 | €4.11 | 81.850% |
| Puma Biotechnology Inc. | 0 | 2 | 0 | 0 | €8.29 | €5.00 | -39.650% |
| Minerva Neurosciences Inc. | 1 | 3 | 1 | 1 | €2.66 | €3.30 | 24.060% |
| Promis Neurosciences Inc | 0 | 2 | 0 | 0 | €0.086 | €0.040 | -53.704% |
| GNI Group Ltd | 0 | 2 | 0 | 0 | €15.10 | €12.00 | -20.530% |
| Edesa Biotech Inc | 1 | 3 | 0 | 0 | €4.58 | €4.00 | -12.664% |
| XBiotech Inc | 0 | 2 | 0 | 0 | €15.63 | €12.00 | -23.225% |
| Takeda Pharmaceutical Co Ltd | 0 | 1 | 0 | 0 | €27.90 | - | - |
| PhaseBio Pharmaceuticals Inc | 1 | 2 | 0 | 0 | €3.26 | €10.00 | 206.748% |
| Moleculin Biotech Inc | 1 | 2 | 0 | 0 | €3.51 | €6.00 | 71.135% |
| Intercept Pharmaceuticals | 2 | 3 | 1 | 0 | €17.98 | - | - |
| NeuroVive Pharmaceutical AB | 0 | 1 | 0 | 0 | €0.056 | - | - |
| Qualigen Therapeutics Inc. | 0 | 1 | 0 | 0 | €2.72 | - | - |
| Evgen Pharma plc | 0 | 1 | 0 | 0 | €0.088 | - | - |
| PDL BioPharma Inc. | 1 | 2 | 0 | 0 | €2.22 | - | - |
| Saniona AB | 0 | 1 | 0 | 0 | €1.79 | - | - |
| Alterity Therapeutics Ltd. ADR | 0 | 1 | 0 | 0 | €1.27 | - | - |
| Mesoblast Ltd ADR | 0 | 1 | 0 | 0 | €7.85 | - | - |
| Pharming Group | 1 | 2 | 0 | 0 | €1.09 | €1.25 | 14.364% |
